Posts in Portfolio Company News
LogoGarden's Launches New Website and Series B Fundraise

LogoGarden, the Brentwood-based logo design and automated website-creation business, is "in the process of raising" a $2MM Series B capital raise, said Founder and CEO John Williams.

Meanwhile, Williams told VNC he is proud of his "branding dynamo," and hopes larger strategic players view LogoGarden as "a prime acquisition target," given its positioning as a "gateway" to the entrepreneurial sector's growth companies.

Read More
StudioNow Announces Investment Round Led by FCA Venture Partners

StudioNow provides the full spectrum of “Creation to Syndication” empowering companies big and small to create more and do more with their Internet video strategy. They believe that the web will eventually become “one big video” and it is their goal and passion to help their customers obtain and integrate the highest quality resources at the lowest possible cost and time frame. Over the past few years, StudioNow has dramatically increased their revenue and is raising this investment round to capitalize on the opportunity they are seeing in the market.  FCA V’s investment will provide bandwidth to accelerate market growth and hire the key talent needed to scale the company. 

Read More
Clinical Ink Places Electronic Data Capture in the Palms of Researchers' Hands

Ultimately, the hope is that SureSource will become a large suite of software tools that can streamline data collection at any stage of a clinical trial. In the meantime, hundreds of tablets running SureSource have already been distributed around the world, and the platform is making an immediate impact on the cost of research. Combining greater reliability of trial data with measurable savings, and enabling both novel and neglected use cases, Clinical Ink exemplifies best practices in clinical studies.

Read More
NuScriptRX names new CEO

Nashville-based NuScriptRX has named a new chief executive officer.
 
C. Daniel Haron, formerly president of Cigna Pharmacy Management, is the mail-orderinstitutional pharmacy’s new CEO, according toa news release. Haron replaces board memberDonald Taylor, who has served as interim CEO since July 2012.

Read More